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ABSTRACT
Genome-wide association studies (GWASs), now as
a routine approach to study single-nucleotide poly-
morphism (SNP)-trait association, have uncovered
over ten thousand significant trait/disease asso-
ciated SNPs (TASs). Here, we updated GWASdb
(GWASdb v2, http://jjwanglab.org/gwasdb) which
provides comprehensive data curation and knowl-
edge integration for GWAS TASs. These updates
include: (i) Up to August 2015, we collected 2479
unique publications from PubMed and other re-
sources; (ii) We further curated moderate SNP-trait
associations (P-value < 1.0×10−3) from each orig-
inal publication, and generated a total of 252 530
unique TASs in all GWASdb v2 collected studies;
(iii) We manually mapped 1610 GWAS traits to 501
Human Phenotype Ontology (HPO) terms, 435 Dis-
ease Ontology (DO) terms and 228 Disease Ontology
Lite (DOLite) terms. For each ontology term, we also
predicted the putative causal genes; (iv) We curated
the detailed sub-populations and related sample size
for each study; (v) Importantly, we performed exten-
sive function annotation for each TAS by incorporat-
ing gene-based information, ENCODE ChIP-seq as-
says, eQTL, population haplotype, functional predic-
tion across multiple biological domains, evolutionary
signals and disease-related annotation; (vi) Addition-
ally, we compiled a SNP-drug response association
dataset for 650 pharmacogenetic studies involving
257 drugs in this update; (vii) Last, we improved the
user interface of website.
INTRODUCTION
Ten years’ efforts on genome-wide association study
(GWAS) have produced large numbers of human genetic
variants that are associated with hundreds of medical traits
and diseases. The world of GWAS is evolving rapidly with
improved technologies such as high-density genotyping ar-
ray and next generation sequencing (NGS) (1,2). New di-
rections of GWAS are mostly focused on larger sample
size (3), variants fine-mapping (4), meta-analysis (5), cross-
phenotype association (6), sequencing-based test (7), etc.
These strategies are increasingly employed to pinpoint the
full spectrum of common, low frequency even rare variants
that potentially contribute to human traits and disorders. A
recent study showed that genetic evidence from GWASdb
(8) or OMIM (9) have the potential to double the success
rate of drug development (10), indicating that GWAS is
moving from basic science to translational applications.
Although GWAS Catalog (11) and other databases, such
as PheGenI (12), GWAS Central (13), SNPedia (14), and
GRASP (15), have collected significant trait/disease asso-
ciated SNPs (TASs) at different levels, comprehensive cura-
tion and function annotation of TASs, especially for those
in the noncoding regulatory regions, are still lacking. The
Encyclopedia Of DNA Elements (ENCODE) project (16)
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and Roadmap Epigenomics Project (17) have successfully
identified many functional elements and regulatory units
in the human genome. Meanwhile, different bioinformat-
ics tools have been developed to predict SNP functions in
multiple biological domains (18–20). Unfortunately, very
few GWAS resources have incorporated these information
to annotate TASs. In addition, GWAS usually utilizes nat-
ural language to describe investigated traits. The inconsis-
tent terms used for similar or even identical traits prevent
easy comparison and analysis among different GWASs. In
spite that GWAS Catalog, GWAS Central and previous
publication version ofGWASdb havemappedmanyGWAS
trait/disease descriptions to Experimental Factor Ontology
(EFO) (21), Medical Subject Headings (MeSH) (22) and
Human PhenotypeOntology (HPO) (23), efforts are needed
for continuous integration of up-to-date ontology informa-
tion and GWAS traits.
In this update, we systematically collected TASs, as well
as detailed information for their effect size and investigated
population, from published GWASs. We performed deep
and high-quality curation for moderate effect TASs accord-
ing to related materials of each publication. GWASdb v2
also introduces a batch of new features including new on-
tology mapping, multi-level annotation, causal gene predic-
tion and an updated interactive user interface.
MATERIALS AND METHODS
Data curation and collection
We collected all significant TASs (P-value < 1.0 × 10−5)
fromGWAS Catalog, PheGenI and HuGE (24). Due to the
omissions and different curation standards for these ma-
jor resources, we also searched GWAS publications from
PubMed using key words such as ‘Genome-wide associa-
tion’, ‘genome association’ (Supplementary Methods). To
reduce data redundancy, we first collected GWAS Catalog
data, and then excluded those overlapped data when inte-
grating variants from other datasets and our curation (Sup-
plementary Methods).
Similar to last version, we systematically curated moder-
ately significant TASs from related documents of each orig-
inal GWAS publication. Generally, we collected TASs by
using a P-value of less than 1.0 × 10−3, since many suscep-
tible loci may only show moderate significance in associa-
tion analysis. Variants were extracted from both full text
and supplementary materials following our criteria (Sup-
plementary Methods). In GWASdb v2, we further added
reported effect sizes to characterize SNP-trait associations
besides of P-values, such as odds ratio/beta, 95% CI infor-
mation, text remark of P-value, and risk allele. For each
GWAS, in addition to its PubMed ID or Analysis ID (stud-
ies from PheGenI), we also provide detailed annotation on
sample size and ancestry of initial stage if recorded (known
as sub-populations in GWASdb v2). Then, we categorized
these sub-populations into eight ethnogeographic super-
populations, namely European/Caucasian (EUR), African
(AFR), East Asian (ASN), Native American (AMR),
Hispanic/Latino (HIS), Middle Eastern (MEA), South
Asian (SAN), Oceania (OCN) and ambiguous samples
(OTHER), and recorded the corresponding sample size in-
formation (Supplementary Methods).
Ontology mapping
The inconsistence of original trait/disease descriptions
from different GWASs impedes the large scale integrative
analysis among independent studies. For example, different
studies utilized distinct phenotype descriptions for an iden-
tical disease (e.g. ‘HIV-1 viral setpoint’ and ‘HIV mother-
to-child transmission’ are bothHIV related) or several stud-
ies involved measurement of particular molecules which are
well-recognized biomarkers or risk factors for certain dis-
eases (e.g. ‘Lipoprotein A level’ as a risk factor for coro-
nary heart disease). Meanwhile, ontologies provide a com-
puter friendly structure for semantic integration of biomed-
ical diseases and phenotype terminologies. Therefore, a high
quality mapping of natural language descriptions to for-
mal and consistent ontology systems is an essential but
challenging task. To this end, we used in-house software
MapIn (http://jjwanglab.org/mapin/, unpublished), which
could calculate the similarities between strings, to map var-
ious trait/disease descriptions from different GWASs to
several well-defined ontology systems, including Disease
Ontology (DO) (25), Human Phenotype Ontology (HPO),
and Disease Ontology Lite (DOLite) (26). After automatic
mapping, we manually checked each result to correct error
mapping results and unmapped phenotypes (Supplemen-
tary Methods).
Causal gene prediction
In this update version, we also provided causal gene predic-
tion for each ontology trait/disease using a recent algorithm
PrixFixe (27). Causal genes are usually predicted based on
the closest genomic distance between TASs and genes, and
the candidate prioritization tends to be biased towards well-
studied genes (27). To overcome these obstacles, PrixFixe
utilized a human co-function network to identify function-
ally related genes within GWA loci. In GWASdb v2, for
each ontology trait/disease, we first ranked all the SNPs by
P-values, then selected the top 200 (commonly used num-
ber in PrixFixe) SNPs to perform causal gene prediction.
The exact SNP number was used if it is <200 for a certain
trait/disease (Supplementary Methods).
SNP-drug response dataset collection
Genetic polymorphisms may determine individual variabil-
ity in drug response (28). Detection of correlation between
SNPs and drug response is of great importance for per-
sonalized medicine. To this end, we compiled an inde-
pendent SNP-drug response dataset. The data were col-
lected from (i) GWASs which have been reported as drug-
related studies in GWASdb v2; (ii) DIYgenomics Drug Re-
sponse (http://www.diygenomics.org/webapp/pharma data.
php), which reports variants for 200 drugs from various
references. Drugs were defined according to records from
DrugBank (29) (Supplementary Methods).
Data processing for annotation
For each TAS, we first mapped it to dbSNP142 and
obtained the allele information from the 1000 Genomes
Project (Supplementary Methods). We retrieved correlated
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SNPs in linkage disequilibrium (LD) with this TAS based
on eleven HapMap I+II+III populations or four super
populations from 1000 Genomes Project. Gene and ge-
nomic element data were downloaded from UCSC and
GENCODE. We utilized ENCODE data to annotate the
functional elements at the SNP position. Since GWAS
TASs could map to genomic regions that are responsi-
ble for distinct biological functions, we also used sophis-
ticated software to predict the functional consequences
for different types of TASs across different biological do-
mains, including transcription factor binding and gene
regulation (GWAS3D (30)), microRNA–target interaction
(PolymiRTS (31)), splicing (Skippy (32) andMutPred Splice
(33)), non-synonymous variant in protein function (db-
NSFP (34)), etc. Evolutionary information were also bor-
rowed to annotate variants under different natural selec-
tion, such as positive selection scores (dbPSHP (35)) and
conservation (PhyloP (36) and GERP++ (37)). For disease-
related annotation, we collected genetic evidence informa-
tion from OMIM, GAD (38), ClinVar (39) and COSMIC
(40) (Supplementary Table S2).
Database design
Compared with the previous GWASdb version, we im-
proved the GWASdb v2 architecture by combining jQuery
plugins (such as Highcharts, DataTables and related UI
frontend)with a Perl-basedweb frameworkCatalyst. Anno-
tation information were either stored in MySQL database
or flat files indexed by Tabix (41). We used Circos (42) to
generate globalGWASdb v2 SNPsManhattan plot and per-
sonal genome browser (PGB) (43) to display important an-
notation tracks.
RESULTS
Summary of new features
GWASdb v2 significantly extends the data content by deep
manual curation and comprehensive resources integration.
Compared with existing databases, GWASdb v2 covers the
highest number of GWAS publications in the field (Supple-
mentary Table S3). The extensive data volume for moder-
ate effect SNPs will facilitate the finding of more associa-
tions that imply important biological function. Also, we up-
dated well-organized trait/disease-ontology mappings in-
cludingHPO,DO andDOLite, which will assist an effective
trait organization. For mapped ontology terms, GWASdb
v2 provides putative causal genes. Moreover, GWASdb v2
now clearly classifies each GWAS to respective sub- and
super-populations, which will benefit researchers in study-
ing population-specific traits. In addition, GWASdb v2 has
collected a SNP-drug response dataset which could poten-
tially benefit for pharmacogenetic research. Last but not
least, GWASdb v2 compiles a complete annotation in both
interactive web pages and local datasets. These annota-
tion and visualization functions will help users pinpoint
the functional attributes of TASs. Detailed improvements
in GWASdb v2 since last publication version is shown in
Supplementary Table S4.
Statistics of GWASdb v2
Based on August 2015 version of GWASdb v2, 2479 unique
GWASs have been collected and curated, which totally
included 297 670 SNP-trait/disease associations (40 248
reached genome wide significance level with P-value < 5.0
× 10−8 and 257 422 had the moderate effect size with P-
value < 1.0 × 10−3). Apart from SNPs collected from ex-
isting GWAS resources (GWAS Catalog, HuGE, and Phe-
GenI, Supplementary Table S1), GWASdb v2 further cu-
rated 266 338 TASs by ourselves. GWASdb v2 contained
252 530 unique TASs. Among them, about 17% were re-
ported by more than one cohort (i.e. different popula-
tions) and over 21% were associated with more than one
trait/disease (according to DOLite mapping results), sug-
gesting that many GWAS SNPs have shared association
across human populations and are relevant to multiple ge-
netic traits. Also, we observed an unbalanced distribution
(Supplementary Figure S1) for the number of TASs in three
major human populations (EUR,AFR andASN) although
current GWASs tend to investigate more worldwide popu-
lations. Majority of TASs are associated with several top
investigated traits/diseases (according to DO or HPOmap-
ping results, Supplementary Figure S2), including nervous
system disorders (e.g., Parkinson’s disease, Alzheimer’s dis-
ease, and bipolar disorder), metabolic disorders (e.g., type
2 diabetes and obesity), cardiovascular diseases (e.g. my-
ocardial infarction, hypertension, and arteriosclerosis) and
immunological diseases (e.g. Systemic lupus erythematosus
and lymphoma). The genomic distribution of GWASdb v2
TASs (Supplementary Figure S3) showed that 105 893 of
them locate in the intergenic region and most of remaining
genic TASs (92.8%) come from intronic region, indicating
the regulatory role of these non-coding genetic variants.
In GWASdb v2, we were able to map 88% of variants
to DO, 99% of variants to HPO, and 87% of variants to
DOLite. We also collected and reported the EFO mapping
from GWAS Catalog and the MeSH mapping from previ-
ous publication (10). These mapping repositories offer the
largest GWAS phenotype-ontology resources (Supplemen-
tary Table S3). Additionally, 650 pharmacogenetic studies
were collected with 524 studies from DIYgenomics Drug
Response and 126 studies from GWASdb v2. In the cur-
rent dataset, 257 drugs including FDA-approved (∼93%)
and experimental (∼3%) drugs were recorded.
Annotation of GWASdb v2 TASs
We utilized over 40 different datasets and prediction tools
to annotate all GWASdb v2 TASs (Table 1), including gene-
based information, knowledge-based information, biologi-
cal function prediction across multiple domains, evolution-
ary signals and disease-related evidence. GWASdb v2 pro-
vides both interactive annotation web pages and download-
able annotation files for each TAS. According to the func-
tional prediction of GWAS leading variants that achieved
genome wide significance level, we found 12.1% TASs are
predicted to affect at least one biological domain including
transcription factor binding, alternative splicing, miRNA-
target recognition, protein-function alternation, and pro-
tein phosphorylation. Compared with dataset randomly
drawn from dbSNP 142 (3.3% have predicted effects), cur-
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Table 1. Annotation items of GWASdb v2
SNP
information
Gene-based
annotation
Knowledge-
based
annotation
Functional
prediction
Evolution
annotation
Disease
annotation External link
Annotations Manually
curated (250k),
dbSNP 142,
1000G phase I,
HapMap and
1000G LD
RefGene, En-
sembleGene,
KnownGene,
GENCODE,
Small RNA,
MicroRNA
target sites
Validated and
predicted
enhancer,
Insulator,
HapMap and
GTEx eQTL,
Long range
interaction
(5C,
ChIA-PET,
Hi-C),
ENCODE
ChIP-seq,
ENCODE
functional
elements
Transcriptional
factor binding
site affinity,
MicroRNA
target site
affinity,
Splicing site
affinity, Non-
synonymous
SNP functional
prediction,
Synonymous
SNP functional
prediction,
Phosphoryla-
tion site
functional
prediction
Positive
selection,
Conserved
functional
RNA,
PhastCons,
GERP++
elements
OMIM,
ClinVar,
Cosmic, DGV,
GAD
SNPedia,
Regulomedb,
HaploReg,
rSNPBase, UCSC
Genome Browser,
GWAS central
Note: 1000G: 1000 Genomes Project; HapMap: The International HapMap Project; ENCODE: Encyclopedia Of DNA Elements; 5C: Carbon-Copy
Chromosome Conformation Capture; ChIA-PET: Chromatin Interaction Analysis by Paired-End Tag Sequencing; DGV: Database of Genomic Variants;
GAD: Genetic Association Database.
rent GWASdb v2 TASs are significantly enriched in affect-
ing biological functions (P < 2.2 × 10−16, Pearson’s chi-
squared test). This result is consistent with previous studies
that GWAS SNPs are enriched in functional elements (44),
eQTL (45) and positive selection signal (46).
Comparison with existing resources
Since different GWAS resources follow different SNP col-
lection criteria (e.g. various P-value threshold), it is un-
fair to directly compare the data volume with them. We al-
ternatively compared the database features in different as-
pects (Supplementary Table S3). In general, the strengths
of GWASdb v2 lie in the following aspects: (i) GWASdb v2
is the largest resource that collects the most GWAS pub-
lications; (ii) GWASdb v2 provides manually curated and
high-quality SNPs which have less significance but poten-
tially association effects; (iii) GWASdb v2 supports a couple
of useful and comprehensive embedded functions (ontology
mapping, causal gene prediction, annotation, drug response
dataset, visualization, web services, etc). Therefore, to the
best of our knowledge, GWASdb v2 is the most compre-
hensive database in the GWAS community.
Usage of the GWASdb v2 web interface
GWASdb v2 provides four types of query entries (namely
dbSNP ID, gene symbol, chromosome region, and trait
name) for users to quickly inspect TASs of interest. It also
offers a batch query function to allow users to upload a SNP
list containing either SNP IDs or genomic coordinates. A
query job will run in the backend, and users can provide
their emails or keep the job URL to retrieve their results,
which is downloadable and contains detailed GWAS infor-
mation and SNP annotation. In the front page of GWASdb
v2, a circos Manhattan plot shows summary of the latest
GWASdb v2 TASs in the whole genome. Users can also en-
ter into the single chromosome view by clicking correspond-
ing chromosome cytoband. The basic statistics of GWASdb
v2 are shown in the right tab of the front page, such as re-
gional distribution and SNP type distribution in genic re-
gion.We improved the GWASdb v2 result page and made it
more compact and integrative compared with previous ver-
sion. We used an interactive panel to display the TASs in
region of interest, users can perform moving, zooming and
clicking operations to visualize the region within this panel
(Figure 1A). The right tab panel of the result page summa-
rizes the association information of current TAS including
variant locus, the number of independent GWASs, related
traits/diseases and populations (Figure 1B). There is also a
table list to show detailed association information for each
study. We incorporated a genome browser, where users can
easily check surrounding genomic features for queried TAS
such as RefGene, EnsembleGene, KnownGene, OMIMdis-
ease gene, and regulatory enhancer (Figure 1C). To display
the annotation of queried TAS, GWASdb v2 uses a separate
window to present comprehensive information by clicking
the ‘Annotate Current Variant’ button. The LDpanel shows
the correlated SNPs for the queried leading TAS. Users can
also change the LD reference and investigated population
(elevenHapMap populations or four 1000Genomes Project
populations) (Figure 1D). Annotation information is clas-
sified into six major categories in interactive multi-tabs, in-
cluding TAS summary, genomic elements, functional pre-
diction, evolution, disease related evidence, as well as sev-
eral convenient external links to DMDM (47), SNPedia,
Regulomedb (48), HaploReg (49), rSNPBase (50), UCSC
Genome Browser (51) and GWAS Central (Figure 1E).
To simplify the visualization of trait/disease ontology
mapping, we embedded the whole ontology of HPO and
DO to one page coupled with query function by the tree
viewer and search box (Figure 2A). To query a particu-
lar trait, users could click the ‘Check Selected Trait’ but-
ton. In the particular trait page, there are three tabs:
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Figure 1. Main functions of GWASdb v2. (A) Interactive Manhattan panel; (B) TAS summary information; (C) Genome browser to show important
functional elements; (D) Interactive LD panel; (E) GWASdb v2 annotation tabs.
‘Loci overview’, ‘Trait variants’ and ‘Gviewer’. In ‘Loci
overview’, an interactive circos plot of all the SNPs asso-
ciated with that trait across the genome is shown (Figure
2B). Users could further (i) check TASs on chromosome
of interest by clicking on corresponding circle band; (ii)
see TASs in a table view by clicking ‘Variant Table of Cur-
rent Trait’ button; (iii) obtain putative causal genes in a ta-
ble by clicking the ‘Putative Causal Genes of Trait’ button;
or (iv) switch to other ontology terms by simply clicking
on ‘Change Ontology Term’ button. Tab ‘Trait variants’ is
available for individual TAS check in a chromosome-based
Manhattan panel (Figure 1A). Tab ‘Gviewer’ provides func-
tion elements in a chromosome-based genome track view
(Figure 1C). We also provided a ‘GWAS Dictionary’ func-
tion which allows users to browse trait/disease in a dictio-
nary manner. A table within the browser will present query
results such as genomic position, PubMed ID and P-values.
GWASdb v2 TASs, ontology mapping and annotation
table can be downloaded via FTP (ftp://jjwanglab.org/
GWASdb/) or remotely retrieved byTabix. Besides, we com-
piled a number of RESTful interfaces to quickly redirect
users to their interested SNPs, genes, regions or traits.
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Figure 2. Trait/disease mapping interface in GWASdb v2. (A) Ontology tree viewer; (B) Genomic overview of SNPs associated with a particular disease.
DISCUSSION
In the past few years, GWASs have discovered a large
number of new genetic loci associated with different
traits/diseases in different human populations by incorpo-
rating larger cohorts, meta-analysis and cross-phenotype
investigation. Since our last publication version of
GWASdb, additional 1540 GWASs have been published
and uncovered 105 993 new associations. As the cost of
NGS is continuously reduced, large-scale whole exome
sequencing (WES) and whole genome sequencing (WGS),
which possess more advantages than GWAS chips to detect
low frequency disease-associated variants, are currently
applied to decipher the genetic association on many
complex diseases (52) and will significantly overcome the
issue of ‘missing heritability’ (53). During this stage, we
have constantly updated GWASdb and released five major
versions in the past three years.
Identification of the true causal and functional variants
from a GWAS leading SNP is usually a tough work, which
requires expensive and time-consuming experiments. Even
though a few statistical methods can facilitate the fine map-
ping of true causal hits (4,54,55), it still lacks functional
evidence to illustrate the role of these variants in biologi-
cal mechanisms, and necessarily requires in-depth investiga-
tion. To this end, GWASdb v2 provides well-organized and
comprehensive annotations for each TAS in various per-
spectives from gene-based information to knowledge-based
functional prediction. Users can easily visualize their inter-
ested SNPs or traits interactively. AlthoughUCSCGenome
Browser and Variant Effect Predictor (VEP) (56) have pro-
vided variant annotations on multiple levels, GWASdb v2
further compiles functional predictions for TASs from dif-
ferent biological domains using prevalent tools. These pre-
dictions and annotations could serve as a valid resource to
prioritize functional variants.
GWASdb now not only focuses on collection of TASs
with significant or moderate effects, but also pays more at-
tention on comprehensive annotation and prioritization of
these variants. A batch of algorithms can accurately predict
the deleteriousness of non-synonymous mutations that di-
rectly alter protein sequences, but for other types of muta-
tions such as variants in regulatory regions, effective algo-
rithms and statistical methods are still in urgent need. Re-
cent works combine multiple genomic data in scoring and
prioritizing functional non-coding variants (57–60), how-
ever, positive datasets and systematic solutions to validate
the prediction power are insufficient (61). In addition to
constant collection of new TASs, one of the major tasks
for GWASdb in the future is to fine-map and exploit the
true functional variants which are causal for disease devel-
opment and abnormal phenotypes.
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